Paid Clinical Trials in Fort Worth, TX
As of September 2026, 331 paid clinical trials are recruiting in Fort Worth, Texas. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Fort Worth offers studies at sites including Cook Children's Medical Center for conditions such as Endometrial Cancer, Ovarian Cancer, Heart Failure, ARDS. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Fort Worth
Trials by drug in Fort Worth
Filter results
Newly added in Fort Worth
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
Effects of Pork Protein on Recovery Following Simulated Fireground Activity
A Study on the Efficacy of a Vaccine Against Influenza in Adults ≥65 Years of Age
AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
A Study to Investigate the Safety and Efficacy of Efimosfermin Alfa Compared With Placebo in Adult Participants With Alcohol-related Liver Disease (ALD)
Studying NMDA and Sigma-1 in Smoking Cessation Treatment (SUMMIT)
303 clinical trials
A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)
A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
A Study of Brenipatide in Adult Participants With Schizophrenia
Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease
A Study of Brenipatide in Adult Participants With Major Depressive Disorder
Study to Evaluate the Safety and Efficacy of Larsucosterol in Participants With Alcohol-associated Hepatitis (AH)
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
A Study to Test Whether BI 3802876 is Tolerated in People With Compensated Liver Cirrhosis Due to Metabolic Dysfunction- Associated Steatohepatitis (MASH)
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy
This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Diabetic Peripheral Neuropathic Pain
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1-Mediated Proteinuric Kidney Disease
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
A Clinical Study of Tulisokibart (MK-7240) to Treat Radiographic Axial Spondyloarthritis (MK-7240-013)
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
Top Research Study Locations in Fort Worth
Researchers run research studies in Fort Worth, TX at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Cook Children's Medical Center | B Acute Lymphoblastic Leukemia, Cystic Fibrosis, Malignant Solid Neoplasm | 54 |
| UT Southwestern/Simmons Cancer Center-Fort Worth | Stage IVB Prostate Cancer AJCC v8, Stage IV Renal Cell Cancer AJCC v8, Endometrial Clear Cell Adenocarcinoma | 30 |
| Cook Children's Health Care System | Langerhans Cell Histiocytosis, Anesthesia, Catheter-Related Infections | 10 |
| Re:Cognition Health - Fort Worth | Alzheimers Disease, Chronic Pain, Depressive Disorder, Major | 7 |
| Cook Children's Hospital | Duchenne Muscular Dystrophy, Hodgkin Lymphoma, ALL | 6 |
| GI Alliance - Fort Worth | Fibrostenotic Crohn's Disease, Metabolic Dysfunction-Associated Steatotic Liver Disease, Moderately to Severely Active Crohns Disease | 5 |
| GSK Investigational Site | Liver Diseases, Alcoholic, Influenza, Human, Multiple Myeloma | 5 |
| JPS Health Network | Asthma, Asthma Attack, Asthma Exacerbations | 5 |
| START Dallas Fort Worth | Adenocarcinoma of Esophagus, Advanced Breast Cancer, Advanced Ovarian Cancer | 5 |
| Texas Christian University | Criminal Behavior, Dementia, Drug Overdose | 5 |
| Baylor All Saints Medical Center | ARDS, ARDS (Acute Respiratory Distress Syndrome), Acute Respiratory Distress Syndrome | 4 |
| John Peter Smith Hospital | Drug-Related Side Effects and Adverse Reactions, Esophageal Squamous Cell Carcinoma, Nausea | 4 |
| Cook Children's | Hematopoietic Cell Transplant, Hemoglobinopathies, Respiratory Viral Infection | 4 |
| Cook Children's Endocrinology | Hypochondroplasia | 3 |
| START Dallas | Advanced Malignancies, G12D Mutated KRAS, Gastric Cancer | 3 |
| START Dallas Fort Worth, LLC | Castration-resistant Prostate Cancer, Castration-resistant Prostate Cancer (CRPC), Colorectal Cancer | 3 |
| Tarrant County Hospital District/JPS Health Network | Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma, Advanced Gastroesophageal Junction Adenocarcinoma | 3 |
| Texas Oncology - DFW | Advanced Non-Small Cell Lung Cancer, Advanced Solid Tumor, Carcinoma, Non-Small-Cell Lung | 3 |
| The Center for Cancer and Blood Disorders | Anemia, Carcinoma, Non-Small-Cell Lung, Myelodysplastic Syndrome | 3 |
| University of North Texas Health Science Center | Chronic Low Back Pain, Hypertension, Memory Impairment | 3 |
| University of Texas Southwestern Simmons Cancer Center - Fort Worth | Advanced Renal Cell Carcinoma, Advanced or Metastatic Renal Cell Carcinoma, Cancer of the Prostate | 3 |
| 89bio Clinical Study Site | Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis, Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis | 2 |
| Baylor Scott & White All Saints Medical Center - Fort Worth | Cancer, Hepatitis | 2 |
| Bob Bolen Public Safety Complex Administration | Blood Biomarkers, Cognition, Exercise Recovery | 2 |
| Clinical Study Site | Metastatic Colorectal Cancer (CRC), Non-Small Cell Lung Cancer | 2 |
Active & Upcoming Studies in Fort Worth (2026)
Recruiting trials in Fort Worth grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (125 active studies)
- A Study to Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Patients With mCRPC Who Were Previously Treated With Abiraterone Acetate (Himalayas-1) · Phase 3 · ORIC Pharmaceuticals
- Gotistobart Long Term Extension (LTE) Study · Phase 3 · OncoC4, Inc.
Cardiovascular (21 active studies)
Neurology & pain (14 active studies)
- A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Chronic Low Back Pain · Phase 2 · Eli Lilly and Company
- A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Osteoarthritis Pain · Phase 2 · Eli Lilly and Company
Diabetes & metabolic (11 active studies)
- Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema · Phase 3 · Novo Nordisk A/S
- AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications · Phase 3 · Novo Nordisk A/S
Mental health & behavior (9 active studies)
- Studying NMDA and Sigma-1 in Smoking Cessation Treatment (SUMMIT) · Phase 3 · Axsome Therapeutics, Inc.
- Justice Community Overdose Innovation Network II TCU Hub · Texas Christian University
Eye & vision (5 active studies)
- A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration · Phase 3 · Amgen
- A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003) · Phase 2, Phase 3 · EyeBiotech Ltd.
Pediatric (4 active studies)
- Repetitive Transcranial Magnetic Stimulation on Motor Function and Meta-Plasticity in Cerebral Palsy: TMS-EEG Study · Cook Children's Health Care System
- KiteLock 4% EDTA Lock Solution for the Prevention of Occlusions in Children With Intestinal Failure · SterileCare Inc.
HIV / STI (2 active studies)
- Study of an Injectable Regimen of GS-3242 With Lenacapavir Compared to Biktarvy in People New to HIV-1 Treatment · Phase 2, Phase 3 · Gilead Sciences
- A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062) · Phase 2, Phase 3 · Merck Sharp & Dohme LLC
Vaccines (1 active study)
- A Study on the Efficacy of a Vaccine Against Influenza in Adults ≥65 Years of Age · Phase 3 · GlaxoSmithKline
Common conditions studied in Fort Worth
- Endometrial Cancer (9 active studies)
- Ovarian Cancer (8 active studies)
- Heart Failure (7 active studies)
- ARDS (5 active studies)
- Acute Respiratory Distress Syndrome (5 active studies)
- Gastric Cancer (5 active studies)
Leading research sponsors in Fort Worth
- National Cancer Institute (NCI)
- Children's Oncology Group
- Eli Lilly and Company
- Merck Sharp & Dohme LLC
- AstraZeneca
Frequently asked questions
How many paid clinical trials are currently recruiting in Fort Worth?
There are approximately 331 recruiting clinical trials in Fort Worth, Texas listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Fort Worth pay participants?
Most recruiting trials in Fort Worth compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Fort Worth?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Fort Worth?
The most common conditions under active study in Fort Worth include Endometrial Cancer (9), Ovarian Cancer (8), Heart Failure (7), ARDS (5), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Fort Worth?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Fort Worth on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Fort Worth?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Fort Worth?
Recruiting research sites in Fort Worth include Cook Children's Medical Center, UT Southwestern/Simmons Cancer Center-Fort Worth, Cook Children's Health Care System, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Fort Worth right now?
The largest active categories in Fort Worth are Cancer & tumors (125), Cardiovascular (21), Neurology & pain (14). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.